Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NS2 in Allergic Conjunctivitis
NCT02578914Phase 2Completed
- Sponsor
- Aldeyra Therapeutics
- Start
- Aug 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of reproxalap in seasonal allergic conjunctivitis (SAC), sponsored by Aldeyra Therapeutics. Started Aug 2015; status: completed.
02
Drugs
reproxalap
03
Conditions
seasonal allergic conjunctivitis (SAC)
Beyond the preview
Go deeper on NCT02578914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02578914.